Skip to main content
. 2023 Feb 9;25(3):1041–1050. doi: 10.1093/europace/euad016

Figure 1.

Figure 1

Two-year chronic complications results. Notes: Hazard ratios of 2-year chronic complication rates between leadless-VVI patients and transvenous-VVI patients for each high-risk subgroup, estimated with Fine–Gray competing risk models. Spikes represent Bonferroni-adjusted confidence intervals (number of tests = 27). aDCSI, adapted Diabetes Complication Severity Index; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; ESRD, end-stage renal disease. ESRD and CKD Stages 4 or 5 are not mutually exclusive.